The Carisoprodol Tablets, cataloged under National Stock Number 6505-00-904-3256, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sciegen Pharmaceuticals Inc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-904-3256 |
| Primary Part Number | NDC50228-0109-01 |
| Item Name | Carisoprodol Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sciegen Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Supplementary Features | MEDSEP ITEM FOR DOD,WAMPOLE LABS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 350.000 MILLIGRAMS CARISOPRODOL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC50742-0656-01 | Ingenus Pharmaceuticals, Llc. Dba Ingenus (USA) |
| NDC50228-0109-01 PRIMARY | Sciegen Pharmaceuticals Inc (USA) |
| NDC00037-2001-01 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00037-2001-01 | 3/9 Design control — primary reference Wampole Laboratories Div of Carter-Wallace Inc |
NSN 6505-00-904-3256 is a Carisoprodol Tablets, manufactured by Sciegen Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-904-3256 has 3 manufacturer part numbers on file: NDC50742-0656-01 (Ingenus Pharmaceuticals, Llc. Dba Ingenus), NDC50228-0109-01 (Sciegen Pharmaceuticals Inc), NDC00037-2001-01 (Mylan Pharmaceuticals Inc).
Key specifications for NDC50228-0109-01: Primary Container Content Quantity: 100.000 TABLETS; Supplementary Features: MEDSEP ITEM FOR DOD,WAMPOLE LABS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.